HIGHLIGHTS
- who: Maddalena Marconato et al. from the Department of Internal Medicine, University Hospital Tu00fcbingen, Tu00fcbingen, Germany have published the article: Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome, in the Journal: Cancers 2022, 4659 of /2022/
- what: The authors now investigated the impact of the diversity of the immunopeptidome on clinical features and disease outcome of 57 CLL patients. 58% of patients presented unmutated IgHV, while 22% of the subjects included in the study presented either a TP53 mutation or a del17p. The study demonstrates the association between the diversity of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.